Plus Therapeutics (PSTV) Registration filing summary

Management team and governance

• Principal executive offices located in Houston, Texas, with Andrew Sims as CFO and Marc H. Hedrick, M.D. as President and CEO.

• Board includes Richard J. Hawkins (Chairman), An van Es-Johansson, Howard Clowes, Kyle Guse, and Ronald A. Andrews.

• Registration statement signed by executive officers and directors as of June 5, 2026.

Offering details and pricing

• Registration statement filed as a pre-effective amendment to Form S-3, allowing for delayed or continuous offerings under Rule 415.

• Securities may be offered from time to time after the effective date.

• Equity Distribution Agreement with Canaccord Genuity LLC dated June 1, 2026.

Underwriters and syndicate

• Canaccord Genuity LLC is named as the counterparty in the Equity Distribution Agreement.